Imayama S - Search Results

1

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study.

Ohba F, Matsuki S, Imayama S, Matsuguma K, Hojo S, Nomoto M, Akama H. Ohba F, et al. Among authors: imayama s. J Dermatolog Treat. 2016 Oct;27(5):467-72. doi: 10.3109/09546634.2016.1157257. Epub 2016 Apr 14. J Dermatolog Treat. 2016. PMID: 27080209 Free article. Clinical Trial.

2

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study.

Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K, Yamamoto M, Mihara R, Kabashima K, Ruzicka T, Hanifin J, Kumagai Y. Nemoto O, et al. Among authors: imayama s. Br J Dermatol. 2016 Feb;174(2):296-304. doi: 10.1111/bjd.14207. Epub 2015 Dec 19. Br J Dermatol. 2016. PMID: 26409172 Clinical Trial.

3

Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis.

Toshitani A, Imayama S, Shimozono Y, Yoshinaga T, Furue M, Hori Y. Toshitani A, et al. Among authors: imayama s. J Dermatol Sci. 1999 Feb;19(2):134-8. doi: 10.1016/s0923-1811(98)00056-5. J Dermatol Sci. 1999. PMID: 10098705

4

Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunization.

Fujiyama T, Oze I, Yagi H, Hashizume H, Matsuo K, Hino R, Kamo R, Imayama S, Hirakawa S, Ito T, Takigawa M, Tokura Y. Fujiyama T, et al. Among authors: imayama s. J Dermatol Sci. 2014 Jul;75(1):43-8. doi: 10.1016/j.jdermsci.2014.04.005. Epub 2014 Apr 16. J Dermatol Sci. 2014. PMID: 24802712 Clinical Trial.

5

An AIDS patient with atopic dermatitis-like eruption responsive to systemic anti-fungal treatment.

Hoashi M, Imayama S, Hori Y, Kashiwagi S. Hoashi M, et al. Among authors: imayama s. J Dermatol. 1992 Dec;19(12):972-5. doi: 10.1111/j.1346-8138.1992.tb03815.x. J Dermatol. 1992. PMID: 1293191

6

Reduction of environmental mites improved atopic dermatitis patients with positive mite-patch tests.

Kubota Y, Imayama S, Hori Y. Kubota Y, et al. Among authors: imayama s. J Dermatol. 1992 Mar;19(3):177-80. doi: 10.1111/j.1346-8138.1992.tb03202.x. J Dermatol. 1992. PMID: 1640023

7

Reduced secretion of IgA to skin surface of patients with atopic dermatitis.

Imayama S, Shimozono Y, Hoashi M, Yasumoto S, Ohta S, Yoneyama K, Hori Y. Imayama S, et al. J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):195-200. doi: 10.1016/0091-6749(94)90040-x. J Allergy Clin Immunol. 1994. PMID: 8064071

8

Secretion of IL-2, IL-4, and IFN-gamma for dust mite antigens in a patient with atopic dermatitis.

Kubota Y, Koga T, Imayama S, Hori Y. Kubota Y, et al. Among authors: imayama s. J Dermatol. 1993 Feb;20(2):85-7. doi: 10.1111/j.1346-8138.1993.tb03836.x. J Dermatol. 1993. PMID: 8478491

9

Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis.

Yoshida A, Imayama S, Sugai S, Kawano Y, Ishibashi T. Yoshida A, et al. Among authors: imayama s. Br J Ophthalmol. 1997 May;81(5):402-6. doi: 10.1136/bjo.81.5.402. Br J Ophthalmol. 1997. PMID: 9227207 Free PMC article.

10

Combination of patch test and IgE for dust mite antigens differentiates 130 patients with atopic dermatitis into four groups.

Imayama S, Hashizume T, Miyahara H, Tanahashi T, Takeishi M, Kubota Y, Koga T, Hori Y, Fukuda H. Imayama S, et al. J Am Acad Dermatol. 1992 Oct;27(4):531-8. doi: 10.1016/0190-9622(92)70218-5. J Am Acad Dermatol. 1992. PMID: 1401304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters